ID: ALA4854350

Max Phase: Preclinical

Molecular Formula: C29H39NO9

Molecular Weight: 545.63

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COC(=O)[C@@H]1C[C@@H](O[C@H]2O[C@@H]3O[C@@]4(C)CC[C@H]5[C@H](C)CC[C@@H]([C@H]2C)[C@@]35OO4)CN1C(=O)OCc1ccccc1

Standard InChI:  InChI=1S/C29H39NO9/c1-17-10-11-22-18(2)25(36-26-29(22)21(17)12-13-28(3,37-26)38-39-29)35-20-14-23(24(31)33-4)30(15-20)27(32)34-16-19-8-6-5-7-9-19/h5-9,17-18,20-23,25-26H,10-16H2,1-4H3/t17-,18-,20-,21+,22+,23+,25+,26-,28-,29-/m1/s1

Standard InChI Key:  GBSKRNBAVNHRNS-YDRPBWNPSA-N

Associated Targets(non-human)

Cysteine protease falcipain-2 149 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 545.63Molecular Weight (Monoisotopic): 545.2625AlogP: 4.16#Rotatable Bonds: 5
Polar Surface Area: 101.99Molecular Species: NEUTRALHBA: 9HBD: 0
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 4.85CX LogD: 4.85
Aromatic Rings: 1Heavy Atoms: 39QED Weighted: 0.40Np Likeness Score: 1.83

References

1. Aratikatla EK, Kalamuddin M, Rana KC, Datta G, Asad M, Sundararaman S, Malhotra P, Mohmmed A, Bhattacharya AK..  (2021)  Combating multi-drug resistant malaria parasite by inhibiting falcipain-2 and heme-polymerization: Artemisinin-peptidyl vinyl phosphonate hybrid molecules as new antimalarials.,  220  [PMID:33901900] [10.1016/j.ejmech.2021.113454]

Source